Until recently, intrinsically disordered proteins (IDPs) and regions (IDRs) were considered implausible as biologically relevant entities. The success of X-ray crystallography and the abundance of well-folded structures in the Protein Data Bank reinforced a rigid structure-function paradigm rooted in the “lock and key” model and the central dogma. In this view, proteins were treated as rigid solids, with dynamics reduced to small fluctuations around a single energy minimum.
IDPs challenge this perspective by existing as dynamic, flexible ensembles rather than fixed three-dimensional structures. This plasticity allows them to adopt multiple conformations, interact with diverse partners, and be finely regulated by post-translational modifications. Their versatility highlights the need for a new framework in molecular biology, one that recognizes proteins as soft matter and embraces structural disorder as a functional principle.
Within the expansive field of (un)Structural Biology, we study the roles of IDPs and IDRs in cellular compartmentalization, with a particular focus on secretory pathways. We also investigate how their dysfunction contributes to diseases such as amyotrophic lateral sclerosis. To address these questions, we integrate biophysical and biochemical methods, including circular dichroism, fluorescence, hydrodynamics, scattering techniques, advanced microscopy, biochemical assays, and NMR, to uncover the molecular mechanisms by which disorder drives function and pathology.
The Golgi complex, with its distinctive stack of flattened cisternae, is one of the most recognisable organelles in eukaryotic cells. Its “pancake-like” morphology enhances vesicle tethering, trafficking efficiency, and processing capacity, yet the molecular determinants of this unique architecture remain poorly understood. The high elasticity of the organelle, which allows it to fragment and reassemble during mitosis, further underscores its dynamic nature and the need for precise structural regulation. Central to this organisation are the Golgi matrix proteins (GMPs), primarily the Golgins and GRASPs. Both families are enriched in intrinsic disorder and multivalent interaction motifs, features increasingly associated with biomolecular condensation. Golgins form extended coiled-coil structures that capture vesicles and tether cisternae, while GRASPs, anchored to membranes via post-translational modifications, mediate golgin-arrestment and Golgi ribbon formation. Together, they provide the scaffold that sustains Golgi integrity, positioning, and dynamics.
In our group, we investigate how GMPs collectively regulate Golgi structure and function, utilising complementary models across species. In yeast, we investigate the Bug1–Grh1 complex as a minimal ancestral system to probe supramolecular assembly, condensate formation, and membrane anchoring. In higher eukaryotes, we study Golgin-45-GRASP55, a medial–trans complex essential for ribbon formation and control of membrane curvature. We also examine how N-terminal acetylation of Grh1 modulates biomolecular condensation, oligomerisation, and liquid–solid transitions. In parallel, we investigate TMED/p24 transmembrane proteins, partners of GRASPs, which may act as cargo receptors and unconventional secretion channels, linking matrix proteins to membrane remodelling.
By integrating spectroscopy, calorimetry, high-resolution microscopy, and cryo-EM, we aim to decipher how GMPs generate the Golgi’s characteristic morphology. These studies not only test the hypothesis of a “liquid-crystalline Golgi”, where condensates shape membranous spaces, but also provide insight into how disruption of these structural proteins might contribute to cancer development (where Golgi fragmentation is commonly observed) and secretion-related disorders.
A recent breakthrough in biology was the discovery that membrane-less organelles, or biomolecular condensates, form within cells through a process known as phase separation (PS). These compartments, composed of proteins and RNAs, provide dynamic microenvironments without the need for surrounding membranes. Examples include processing bodies, stress granules, germ P granules, nucleoli, Cajal bodies, and PML bodies. Although Flory and Huggins established the thermodynamic principles of liquid-liquid phase separation in the 1940s, its role in cell biology was only recognised in 2009, when P granules in worm embryos were identified as liquid-like condensates. Since then, PS has emerged as a central organising principle in both healthy physiology and disease.
In our group, PS is studied as a key mechanism in the organisation of secretory organelles, unconventional secretion under stress, and the pathogenesis of neurodegenerative disorders. A major focus is the protein Annexin A11 (ANXA11), a calcium-dependent phospholipid-binding protein with a long intrinsically disordered N-terminal region. ANXA11 is implicated in cancer, autoimmune diseases, and neurodegeneration, and mutations in its disordered domains are directly linked to amyotrophic lateral sclerosis (ALS) and multisystem proteinopathies. These mutations alter its ability to undergo PS and to regulate stress granule dynamics, often triggering aberrant liquid-to-solid transitions. Beyond ANXA11, we investigate the interplay of FUS and TDP-43, central components of stress granules whose condensation properties are finely tuned in healthy cells but prone to pathological aggregation in ALS and frontotemporal dementia (FTLD). By combining recombinant protein biophysics and advanced imaging, we aim to elucidate how pathogenic variants impact the co-condensation, stability, and maturation of these assemblies.
Together, these projects explore how intrinsically disordered proteins form, regulate, and sometimes misregulate condensates. By uncovering the physical rules that govern their assembly, we seek to understand how condensates contribute to cellular organisation, and how their dysfunction drives neurodegeneration and other diseases.
Functional amyloids are highly ordered protein assemblies that, unlike their pathological counterparts, play essential physiological roles. In our group, we investigate these systems in contexts ranging from microbial resistance to neuroendocrine regulation.
One research line focuses on bacterial biofilms, where amyloid fibres such as curli provide structural stability and promote antibiotic resistance. We study the protein CsgA, the main structural unit, using biophysical kinetics, high-throughput screening, and cryo-EM to identify inhibitors and disassembly mechanisms that could weaken biofilms. Complementarily, we investigate CsgC, a periplasmic chaperone that prevents premature aggregation of CsgA. By characterising its structure, stability, and interactions, we aim to understand how amyloid biogenesis is regulated at the molecular level and how this process could be targeted to combat antimicrobial resistance.
A second front examines neuropeptide hormones, which are stored in secretory granules as reversible amyloid condensates. We investigate the aggregation and disassembly of CRH and Neuropeptide Y, key regulators of stress and anxiety, using a combination of biophysical and structural approaches to uncover how cells control amyloid-mediated storage and release. Finally, we are advancing the study of heteromeric amyloids, exploring whether β-endorphin and ACTH (co-localised in secretory vesicles) can form mixed fibrils. By characterising their co-aggregation kinetics and supramolecular organisation, we aim to expand the concept of functional amyloids beyond homopolymeric assemblies.
Together, these projects highlight the duality of amyloids: as a major challenge in infectious diseases and as finely tuned mechanisms in physiology. Our goal is to uncover their molecular rules and translate this knowledge into biomedical and pharmacological insights.